Matrix metalloproteinase2 and 9 and tissue inhibitor of metalloproteinase1 and 2 in sera and urine of patients with renal carcinoma

By  

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 621-626

Spandidos Publications

Access to resources Recommend Favorite

Differential Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Protein and mRNA in Epithelial Ovarian Tumors

By Huang L.-W.   Garrett A.P.   Bell D.A.   Welch W.R.   Berkowitz R.S.   Mok S.C.  

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 369-376

Elsevier

Access to resources Recommend Favorite

Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma

By Tas Faruk   Duranyildiz Derya   Oguz Hilal   Camlica Hakan   Yasasever Vildan   Topuz Erkan  

Medical Oncology, Vol. 25, Iss. 4, 2008-12 ,pp. : 431-436

Humana Press, Inc

Access to resources Recommend Favorite

Impact of losartan and angiotensin II on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat vascular smooth muscle cells

By  

Molecular Medicine Reports, Vol. 11, Iss. 3, 2015-01 ,pp. : 1587-1594

Spandidos Publications

Access to resources Recommend Favorite

Serum Matrix Metalloproteinase-2 as a Prognostic Marker in Advanced Cutaneous Melanoma

By Vuoristo Meri-Sisko   Kellokumpu-Lehtinen Pirkko   Parvinen Leena-Maija   Hahka-Kemppinen Marjo   Korpela Merja   Kumpulainen Eero   Laine Seppo  

Acta Oncologica, Vol. 39, Iss. 7, 2000-11 ,pp. : 877-879

Informa Healthcare

Access to resources Recommend Favorite